Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Breast Cancer Research : BCR|October 31, 2013
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancerShuiliang Wang, Jingcao Huang, Hui Lyu, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2013
Glucose promotes breast cancer aggression and reduces metformin efficacyReema Wahdan-Alaswad, Zeying Fan, Susan M Edgerton, et al.
Oncotarget|September 24, 2017
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cellsMing Zhao, Erin W Howard, Amanda B Parris, et al.
Scientific Reports|May 3, 2018
Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cellsHarry Lee, Nipun Saini, Erin W Howard, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2011
Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survivalA M Brewster, P Thompson, A A Sahin, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Journal of the National Cancer Institute|June 3, 1992
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancersA D Thor, I I Moore DH, S M Edgerton, et al.
Cancer Research|December 15, 1989
Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-upA D Thor, L H Schwartz, F C Koerner, et al.
Cancer Research|May 17, 2003
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic miceXiaoHe Yang, Susan M Edgerton, Stanley D Kosanke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2017
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression <i>In Vivo</i>L Allyson Checkley, Michael C Rudolph, Elizabeth A Wellberg, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|October 31, 2013
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancerShuiliang Wang, Jingcao Huang, Hui Lyu, et al.
Cell Cycle (Georgetown, Tex.)|October 11, 2013
Glucose promotes breast cancer aggression and reduces metformin efficacyReema Wahdan-Alaswad, Zeying Fan, Susan M Edgerton, et al.
Oncotarget|September 24, 2017
Activation of cancerous inhibitor of PP2A (CIP2A) contributes to lapatinib resistance through induction of CIP2A-Akt feedback loop in ErbB2-positive breast cancer cellsMing Zhao, Erin W Howard, Amanda B Parris, et al.
Scientific Reports|May 3, 2018
Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cellsHarry Lee, Nipun Saini, Erin W Howard, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2011
Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survivalA M Brewster, P Thompson, A A Sahin, et al.
Breast Cancer Research and Treatment|July 24, 2012
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signaturesPeter Kabos, Jessica Finlay-Schultz, Chunling Li, et al.
Journal of the National Cancer Institute|June 3, 1992
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancersA D Thor, I I Moore DH, S M Edgerton, et al.
Cancer Research|December 15, 1989
Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-upA D Thor, L H Schwartz, F C Koerner, et al.
Cancer Research|May 17, 2003
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic miceXiaoHe Yang, Susan M Edgerton, Stanley D Kosanke, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2017
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression <i>In Vivo</i>L Allyson Checkley, Michael C Rudolph, Elizabeth A Wellberg, et al.
Pageof 9